AvenCell Therapeutics

Last updated: October 31, 2025
CEO - Andrew Schiermeier
CEO - Andrew Schiermeier
Country: USA | Funding: $152M (+)

Website: https://www.avencell.com/

AvenCell Therapeutics develops next generation immunotherapies for hard-to-treat cancers.

Competitors